Case number 2018-2232
Kaken Pharmaceutical Co., Ltd. v. Iancu > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | KAKEN PHARMACEUTICAL CO., LTD. v. IANCU [OPINION] [precedential] (0) |
| May 4, 2020 | 89 | Mandate issued to the United States Patent and Trademark Office. Service as of this date by the Clerk of Court. [691922] [JAB] [Entered: 05/04/2020 12:05 PM] (0) |
| Mar 13, 2020 | 87 | OPINION filed for the court by Newman, Circuit Judge; O'Malley, Circuit Judge and Taranto, Circuit Judge. Precedential Opinion. [678490] [JAB] [Entered: 03/13/2020 09:59 AM] (0) |
| Mar 13, 2020 | 88 | JUDGMENT. REVERSED IN PART, VACATED, AND REMANDED. Terminated on the merits after oral argument. COSTS: Costs awarded to appellants. Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [678492] [JAB] [Entered: 03/13/2020 10:01 AM] (0) |
| Feb 4, 2020 | 86 | Submitted after ORAL ARGUMENT by John D. Livingstone for Bausch Health Companies Inc. and Kaken Pharmaceutical Co., Ltd. and Mr. Nicholas Theodore Matich, IV for Iancu. Panel: Judge: Newman , Judge: O'Malley , Judge: Taranto. [668166] [JCP] [Entered: 02/04/2020 10:13 AM] (0) |
| Jan 31, 2020 | 85 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Intervenor Iancu. Service: 01/31/2020 by email. [667589] [18-2232] [Nicholas Matich] [Entered: 01/31/2020 10:47 AM] (0) |
| Jan 16, 2020 | 83 | Notice to counsel for Appellant Bausch Health Companies Inc.: The record of this case indicates that the Response to Notice of Oral Argument has not been filed. The response was due on or before 01/15/2020. Counsel must promptly docket the response. Service as of this date by the Clerk of Court. [663687] [JAB] [Entered: 01/16/2020 09:49 AM] (0) |
| Jan 16, 2020 | 84 | Corrected Response to notice of oral argument from the Appellants Bausch Health Companies Inc. and Kaken Pharmaceutical Co., Ltd.. [663740] [18-2232] [John Livingstone] [Entered: 01/16/2020 10:41 AM] (0) |
| Jan 15, 2020 | 82 | Response to notice of oral argument from the Appellant Kaken Pharmaceutical Co., Ltd.. [663214] [18-2232] [John Livingstone] [Entered: 01/15/2020 11:46 AM] (0) |
| Jan 8, 2020 | 81 | Response to notice of oral argument from the Intervenor Iancu. [661387] [18-2232] [Nicholas Matich] [Entered: 01/08/2020 09:04 AM] (0) |
| Jan 7, 2020 | 80 | NOTICE OF ORAL ARGUMENT. Panel: 2002E. Case scheduled February 4, 2020 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 402. Response to Notice of Oral Argument due: 01/15/2020. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [661289] [JAB] [Entered: 01/07/2020 02:10 PM] (0) |
| Dec 4, 2019 | 79 | Entry of appearance for Cora R. Holt as of counsel for Appellants Kaken Pharmaceutical Co., Ltd. and Bausch Health Companies Inc.. Service: 12/04/2019 by email. [653976] [18-2232] [Cora Holt] [Entered: 12/04/2019 01:09 PM] (1) |
| Dec 3, 2019 | 78 | Notice from Intervenor Iancu regarding conflicts with oral argument. Service: 12/03/2019 by email. [653563] [18-2232] [Nicholas Matich] [Entered: 12/03/2019 11:42 AM] (1) |
| Nov 27, 2019 | 77 | Entry of appearance for Nicholas T. Matich as principal counsel for Intervenor Iancu. Service: 11/27/2019 by email. [652926] [18-2232] [Nicholas Matich] [Entered: 11/27/2019 03:13 PM] (2) |
| Nov 7, 2019 | 76 | Entry of appearance for Farheena Y. Rasheed as of counsel for Intervenor Iancu. Service: 11/07/2019 by email. [647916] [18-2232] [Farheena Rasheed] [Entered: 11/07/2019 04:43 PM] (2) |
| Nov 6, 2019 | 75 | The following conflict dates submitted by Attorney John D. Livingstone for Appellants Bausch Health Companies Inc. and Kaken Pharmaceutical Co., Ltd. have been accepted by the court: 01/06/2020, 01/07/2020, 01/08/2020, 01/09/2020, 01/10/2020, 06/01/2020, 06/02/2020, 06/03/2020, 06/04/2020, 06/05/2020. [647436] [JAB] [Entered: 11/06/2019 02:43 PM] (0) |
| Nov 6, 2019 | 74 | Notice from Appellants Kaken Pharmaceutical Co., Ltd. and Bausch Health Companies Inc. regarding conflicts with oral argument. Service: 11/06/2019 by email. [647409] [18-2232] [John Livingstone] [Entered: 11/06/2019 02:18 PM] (4) |
| Nov 6, 2019 | 73 | Notice from Intervenor Iancu regarding conflicts with oral argument. Service: 11/06/2019 by email. [647294] [18-2232] [Brian Racilla] [Entered: 11/06/2019 12:18 PM] (2) |
| Oct 31, 2019 | 72 | 6 paper copies of the Appendix Brief (Vol. I - II) [63] received from Appellants Bausch Health Companies Inc. and Kaken Pharmaceutical Co., Ltd.. [646873] [CJF] [Entered: 11/05/2019 09:28 AM] (0) |
| Oct 31, 2019 | 71 | 6 paper copies of the Corrected Intervenor Brief [60] received from Intervenor Iancu. [646872] [CJF] [Entered: 11/05/2019 09:27 AM] (0) |
| Oct 31, 2019 | 70 | 6 paper copies of the Corrected Reply Brief [66] received from Appellants Bausch Health Companies Inc. and Kaken Pharmaceutical Co., Ltd.. [646871] [CJF] [Entered: 11/05/2019 09:25 AM] (0) |
| Oct 31, 2019 | 69 | 6 paper copies of the Opening Brief [29] received from Appellants Bausch Health Companies Inc. and Kaken Pharmaceutical Co., Ltd.. [646660] [CJF] [Entered: 11/04/2019 12:10 PM] (0) |
| Oct 30, 2019 | 68 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [645783] [TAM] [Entered: 10/30/2019 11:21 AM] (1) |
| Oct 30, 2019 | 67 | Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(1). [645782] [TAM] [Entered: 10/30/2019 11:21 AM] (0) |
| Oct 30, 2019 | 66 | MODIFIED ENTRY: CORRECTED REPLY BRIEF FILED for Appellants Bausch Health Companies Inc. and Kaken Pharmaceutical Co., Ltd. Number of Pages: 31. Service: 10/30/2019 by email. [645773]--[Edited 10/30/2019 by TAM - compliance review complete] [John Livingstone] [Entered: 10/30/2019 11:04 AM] (45) |
| Oct 30, 2019 | 65 | Notice of Correction to Doc No. [61] for Appellants Kaken Pharmaceutical Co., Ltd. and Bausch Health Companies Inc.. Service: 10/30/2019 by email. [645771] [18-2232] [John Livingstone] [Entered: 10/30/2019 11:02 AM] (3) |
| Oct 30, 2019 | 64 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a) and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [CLERK'S NOTE: Attorney Samhitha Medatia’s contact information listed on the reply brief and the appendix does not match the contact information on the account. Please update ECF account information at www.pacer.gov.] [645768] [TAM] [Entered: 10/30/2019 11:00 AM] (0) |
| Sep 30, 2019 | 63 | MODIFIED ENTRY: APPENDIX FILED for Bausch Health Companies Inc. and Kaken Pharmaceutical Co., Ltd.. Number of Pages: 732. Service: 09/30/2019 by email. [639100] --[Edited 10/30/2019 by TAM - compliance review complete] [John Livingstone] [Entered: 09/30/2019 02:06 PM] (732) |
| Sep 23, 2019 | 61 | MODIFIED ENTRY: REPLY BRIEF FILED for Appellants Bausch Health Companies Inc. and Kaken Pharmaceutical Co., Ltd.. Number of Pages: 31. Service: 09/23/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [637550] --[Edited 10/30/2019 by TAM -compliance review complete] This brief has been corrected. See Doc No.[66] [John Livingstone] [Entered: 09/23/2019 04:25 PM] (45) |
| Sep 23, 2019 | 62 | Amended Certificate of Interest for Appellants Kaken Pharmaceutical Co., Ltd. and Bausch Health Companies Inc.. Service: 09/23/2019 by email. [637551] [18-2232] [John Livingstone] [Entered: 09/23/2019 04:26 PM] (4) |
| Sep 4, 2019 | 59 | Notice of Correction to Doc No. [54] for Intervenor Iancu. Service: 09/04/2019 by email. [632956] [18-2232] [Benjamin Hickman] [Entered: 09/04/2019 09:47 AM] (3) |
| Sep 4, 2019 | 60 | MODIFIED ENTRY: CORRECTED BRIEF FILED for Intervenor Iancu. Number of Pages: 42. Service: 09/04/2019 by email. [632957]--[Edited 09/23/2019 by MMA - Reason: compliance review complete] [Benjamin Hickman] [Entered: 09/04/2019 09:53 AM] (50) |
| Aug 28, 2019 | 58 | NOTICE OF NON-COMPLIANCE: The submission of Intervenor Iancu, Intervenor Brief [54], is not in compliance with the rules of this court (see attached). Compliant document due on 09/05/2019. Service as of this date by the Clerk of Court. [631722]} [TAM] [Entered: 08/28/2019 02:45 PM] (1) |
| Aug 21, 2019 | 57 | **TEXT ONLY** ORDER granting motion to extend time to file Appellant's reply brief [55] filed by Appellants Bausch Health Companies Inc. and Kaken Pharmaceutical Co., Ltd. The reply brief is due 09/23/2019. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [630001] [TAM] [Entered: 08/21/2019 03:10 PM] (0) |
| Aug 21, 2019 | 56 | Amended Certificate of Interest for Appellants Kaken Pharmaceutical Co., Ltd. and Bausch Health Companies Inc.. Service: 08/21/2019 by email. [629929] [18-2232] [John Livingstone] [Entered: 08/21/2019 02:22 PM] (4) |
| Aug 21, 2019 | 55 | MOTION of Appellants Kaken Pharmaceutical Co., Ltd. and Bausch Health Companies Inc. to extend the time to 09/23/2019 to file the 09/02/2019. [Consent: unopposed]. Service: 08/21/2019 by email. [629927] [18-2232] [John Livingstone] [Entered: 08/21/2019 02:21 PM] (9) |
| Aug 19, 2019 | 54 | FILED from Intervenor Iancu. Title: INTERVENOR BRIEF. Service: 08/19/2019 by email. [629401] [18-2232] This document is non-compliant. See Doc No.[58] [Benjamin Hickman] [Entered: 08/19/2019 05:47 PM] (50) |
| Aug 19, 2019 | 53 | Entry of appearance for William LaMarca as of counsel for Intervenor Iancu. Service: 08/19/2019 by email. [629369] [18-2232] [William LaMarca] [Entered: 08/19/2019 04:15 PM] (2) |
| Jul 16, 2019 | 52 | ORDER granting motion to extend time to file the Director's brief [51] filed by Intervenor Iancu. No further extensions should be anticipated. Brief due 08/19/2019. Service as of this date by the Clerk of Court. [621336] [TAM] [Entered: 07/16/2019 01:11 PM] (2) |
| Jul 11, 2019 | 51 | MOTION of Intervenor Iancu to extend the time to 08/19/2019 to file the Director's Brief. [Consent: unopposed]. Service: 07/11/2019 by email. [620302] [18-2232] [Benjamin Hickman] [Entered: 07/11/2019 11:59 AM] (5) |
| Jun 12, 2019 | 50 | Docketing Statement for the Intervenor Iancu. Service: 06/12/2019 by email. [613570] [18-2232] [Benjamin Hickman] [Entered: 06/12/2019 02:30 PM] (3) |
| Jun 12, 2019 | 49 | **TEXT ONLY** ORDER granting motion to extend time to file Intervenor's brief [47] filed by Intervenor Iancu. Brief is due 07/19/2019. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [613434] [TAM] [Entered: 06/12/2019 10:24 AM] (0) |
| Jun 11, 2019 | 48 | Entry of appearance for Brian Racilla as of counsel for Intervenor Iancu. Service: 06/11/2019 by email. [613231] [18-2232] [Brian Racilla] [Entered: 06/11/2019 03:29 PM] (2) |
| Jun 11, 2019 | 47 | MOTION of Intervenor Iancu to extend the time to 07/19/2019 to file the Director's Brief. [Consent: unopposed]. Service: 06/11/2019 by email. [612999] [18-2232] [Benjamin Hickman] [Entered: 06/11/2019 09:42 AM] (5) |
| Jun 3, 2019 | 45 | **TEXT ONLY** ORDER granting motion to withdraw attorney Ashley Winkler as counsel [43] filed by Appellants Bausch Health Companies Inc. and Kaken Pharmaceutical Co., Ltd. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [611057] [TAM] [Entered: 06/03/2019 03:22 PM] (0) |
| Jun 3, 2019 | 46 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entry of appearance Docket No. [44], ERROR: Attorney Samhitha Medatia's contact information listed on the Entry of Appearance does not match the contact information on the account. CORRECTION: Please update ECF account information at www.pacer.gov. [611092] [TAM] [Entered: 06/03/2019 04:03 PM] (0) |
| May 31, 2019 | 44 | Entry of appearance for Samhitha Medatia as of counsel for Appellants Kaken Pharmaceutical Co., Ltd. and Bausch Health Companies Inc.. Service: 05/31/2019 by email. [610699] [18-2232] [John Livingstone] [Entered: 05/31/2019 11:50 AM] (2) |
| May 31, 2019 | 42 | Amended Certificate of Interest for the Appellants Kaken Pharmaceutical Co., Ltd. and Bausch Health Companies Inc.. Service: 05/31/2019 by email. [610690] [18-2232] [John Livingstone] [Entered: 05/31/2019 11:42 AM] (4) |
| May 31, 2019 | 43 | MOTION of Appellants Kaken Pharmaceutical Co., Ltd. and Bausch Health Companies Inc. to withdraw counsel Ashley M. Winkler [Consent: unopposed]. Service: 05/31/2019 by email. [610697] [18-2232] [John Livingstone] [Entered: 05/31/2019 11:47 AM] (5) |
| May 14, 2019 | 41 | ORDER modifying the official caption. Service as of this date by the Clerk of Court. [607121] [TAM] [Entered: 05/14/2019 11:08 AM] (2) |
| May 13, 2019 | 38 | Entry of appearance for Benjamin T. Hickman as principal counsel for Intervenor - Director, U.S. Patent and Trademark Office. Service: 05/13/2019 by email. [606856] [18-2232] [Benjamin Hickman] [Entered: 05/13/2019 12:34 PM] (2) |
| May 13, 2019 | 39 | Entry of appearance for Thomas W. Krause as of counsel for Intervenor - Director, U.S. Patent and Trademark Office. Service: 05/13/2019 by email. [606858] [18-2232] [Thomas Krause] [Entered: 05/13/2019 12:37 PM] (2) |
| May 13, 2019 | 40 | Entry of appearance for Robert J. McManus as of counsel for Intervenor - Director, U.S. Patent and Trademark Office. Service: 05/13/2019 by email. [606860] [18-2232] [Robert McManus] [Entered: 05/13/2019 12:41 PM] (2) |
| May 13, 2019 | 37 | Notice of Intervention pursuant to the provisions of 35 USC Section 143 from the Director of the United States Patent and Trademark Office. Service: 05/13/2019 by email. [606854] [18-2232] [Benjamin Hickman] [Entered: 05/13/2019 12:29 PM] (3) |
| Apr 11, 2019 | 36 | ORDER filed. The revised official caption and short caption are reflected in this order. Within 30 days from the date of filing of this order, the Director of the United States Patent and Trademark Office is directed to inform this court whether he intends to intervene in the above-captioned appeal. (See order for further details.) Service: 04/11/2019 by clerk. [599308] [NL] [Entered: 04/11/2019 12:39 PM] (2) |
| Apr 4, 2019 | 35 | Letter from Appellees Acrux DDS Pty Ltd. and Acrux Limited Notice of non-participation in appeal, brief will not be filed. Service: 04/04/2019 by email. [597989] [18-2232] [William Rakoczy] [Entered: 04/04/2019 06:21 PM] (1) |
| Feb 13, 2019 | 34 | Amended Certificate of Interest for the Appellees Acrux DDS Pty Ltd. and Acrux Limited. Service: 02/13/2019 by email. [585768] [18-2232] [William Rakoczy] [Entered: 02/13/2019 08:42 PM] (5) |
| Feb 13, 2019 | 33 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: motion to extend time to file brief Docket No. [31], ERROR: The certificate of interest included in this motion for Appellees Acrux DDS Pty Ltd. and Acrux Limited includes information not stated in the certificate of interest previously filed for these parties. CORRECTION: If changes have been made a new certificate of interest must be filed. [585634] [TAM] [Entered: 02/13/2019 02:00 PM] (0) |
| Feb 13, 2019 | 32 | ORDER granting motion to extend time to file appellees' response brief [31] filed by Appellees Acrux DDS Pty Ltd. and Acrux Limited. No further extensions should be anticipated. Appellees Acrux DDS Pty Ltd. and Acrux Limited's response brief due 04/29/2019. Service as of this date by the Clerk of Court. [585625] [TAM] [Entered: 02/13/2019 01:47 PM] (2) |
| Feb 6, 2019 | 31 | MOTION of Appellees Acrux DDS Pty Ltd. and Acrux Limited to extend the time to 04/29/2019 to file the Appellees' Response Brief. [Consent: unopposed]. Service: 02/06/2019 by email. [583899] [18-2232] [William Rakoczy] [Entered: 02/06/2019 05:35 PM] (10) |
| Jan 18, 2019 | 30 | Amended Certificate of Interest for the Appellants Kaken Pharmaceutical Co., Ltd. and Bausch Health Companies Inc.. Service: 01/18/2019 by email. [579483] [18-2232] [John Livingstone] [Entered: 01/18/2019 08:41 PM] (5) |
| Jan 18, 2019 | 29 | MODIFIED ENTRY: BRIEF FILED for Appellants Bausch Health Companies Inc. and Kaken Pharmaceutical Co., Ltd. Number of Pages: 65. Service: 01/18/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [579482] --[Edited 02/07/2019 by MMA - Reason: compliance review complete] [John Livingstone] [Entered: 01/18/2019 08:39 PM] (243) |
| Oct 29, 2018 | 28 | **TEXT ONLY** ORDER granting motion to withdraw attorney [26] Erin Forbes filed by Appellees Acrux DDS Pty Ltd. and Acrux Limited. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [560980] [SJ] [Entered: 10/29/2018 02:47 PM] (0) |
| Oct 29, 2018 | 27 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: motion to withdraw attorney Docket No. [26], ERROR: no cert. of compliance with word count requirement. CORRECTION: future motions must contain this certificate. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [560978] [SJ] [Entered: 10/29/2018 02:46 PM] (0) |
| Oct 26, 2018 | 26 | MOTION of Appellees Acrux DDS Pty Ltd. and Acrux Limited to withdraw counsel Erin M. Forbes [Consent: unopposed]. Service: 10/26/2018 by email. [560662] [18-2232] [William Rakoczy] [Entered: 10/26/2018 01:34 PM] (7) |
| Oct 26, 2018 | 25 | Entry of appearance for Cynthia H. Sun as of counsel for Appellees Acrux DDS Pty Ltd. and Acrux Limited. Service: 10/26/2018 by email. [560640] [18-2232] [Cynthia Sun] [Entered: 10/26/2018 12:21 PM] (2) |
| Oct 23, 2018 | 24 | **TEXT ONLY** ORDER granting motion to extend time to file brief [22] filed by Appellants Bausch Health Companies Inc. and Kaken Pharmaceutical Co., Ltd. Brief is due 01/18/2019. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [559522] [JB] [Entered: 10/23/2018 12:47 PM] (0) |
| Oct 23, 2018 | 23 | Official caption revised to reflect lack of appearance on behalf of Argentum Pharmaceuticals LLC. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by the Clerk of Court. [559519] [JB] [Entered: 10/23/2018 12:42 PM] (0) |
| Oct 17, 2018 | 22 | MOTION of Appellants Kaken Pharmaceutical Co., Ltd. and Bausch Health Companies Inc. to extend the time to 01/18/2019 to file the 11/19/2018. [Consent: unopposed]. Service: 10/17/2018 by email. [558153] [18-2232] [John Livingstone] [Entered: 10/17/2018 02:49 PM] (7) |
| Sep 19, 2018 | 21 | Certified list from the United States Patent and Trademark Office. Service: 09/19/2018 by email. Appellant/Petitioner's brief is due 11/19/2018. [551496] [SJ] [Entered: 09/20/2018 04:09 PM] (90) |
| Sep 7, 2018 | 19 | ORDER granting motion to modify the official caption [14] filed by Valeant Pharmaceuticals International, Inc. and Appellant Kaken Pharmaceutical Co., Ltd.. Appellant Valeant Pharmaceuticals International, Inc. is replaced by Bausch Health Companies Inc.. Service as of this date by the Clerk of Court. [547870] [CMP] [Entered: 09/07/2018 09:48 AM] (2) |
| Sep 7, 2018 | 20 | Amended Certificate of Interest for the Appellants Kaken Pharmaceutical Co., Ltd. and Bausch Health Companies Inc.. Service: 09/07/2018 by email. [548053] [18-2232] [John Livingstone] [Entered: 09/07/2018 02:31 PM] (3) |
| Sep 7, 2018 | 18 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a) and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [547855] [CMP] [Entered: 09/07/2018 09:13 AM] (0) |
| Sep 7, 2018 | 17 | Official caption revised to reflect Appellant Valeant Pharmaceuticals International, Inc. now known as Bausch Health Companies Inc.. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by the Clerk of Court. [547834] [CMP] [Entered: 09/07/2018 08:33 AM] (0) |
| Sep 5, 2018 | 16 | Notice to counsel for Appellee Argentum Pharmaceuticals LLC: The record of this case indicates that an entry of appearance, certificate of interest, and docketing statement have not been filed amd are overdue. Please submit the documents promptly. Service as of this date by the Clerk of Court. [547417] [CMP] [Entered: 09/05/2018 03:26 PM] (0) |
| Aug 29, 2018 | 15 | Entry of appearance for Erin M. Forbes as of counsel for Appellees Acrux DDS Pty Ltd. and Acrux Limited. Service: 08/29/2018 by email. [546265] [18-2232] [Erin Forbes] [Entered: 08/29/2018 05:57 PM] (2) |
| Aug 28, 2018 | 14 | MOTION of Appellants Kaken Pharmaceutical Co., Ltd. and Valeant Pharmaceuticals International, Inc. to modify the official caption [Consent: unopposed]. Service: 08/28/2018 by email. [545861] [18-2232] [John Livingstone] [Entered: 08/28/2018 02:45 PM] (8) |
| Aug 24, 2018 | 2 | Entry of appearance for William A. Rakoczy as principal counsel for Appellees Acrux Limited and Acrux DDS Pty Ltd.. Service: 08/24/2018 by email. [545284] [18-2232] [William Rakoczy] [Entered: 08/24/2018 01:18 PM] (2) |
| Aug 24, 2018 | 13 | Certificate of Interest for the Appellants Kaken Pharmaceutical Co., Ltd. and Valeant Pharmaceuticals International, Inc.. Service: 08/24/2018 by email. [545341] [18-2232] [John Livingstone] [Entered: 08/24/2018 02:27 PM] (3) |
| Aug 24, 2018 | 12 | Docketing Statement for the Appellants Kaken Pharmaceutical Co., Ltd. and Valeant Pharmaceuticals International, Inc.. Service: 08/24/2018 by email. [545340] [18-2232] [John Livingstone] [Entered: 08/24/2018 02:25 PM] (4) |
| Aug 24, 2018 | 11 | Entry of appearance for Jeffrey M. Jacobstein as of counsel for Appellants Kaken Pharmaceutical Co., Ltd. and Valeant Pharmaceuticals International, Inc.. Service: 08/24/2018 by email. [545337] [18-2232] [John Livingstone] [Entered: 08/24/2018 02:24 PM] (2) |
| Aug 24, 2018 | 10 | Entry of appearance for Ashley M. Winkler as of counsel for Appellants Kaken Pharmaceutical Co., Ltd. and Valeant Pharmaceuticals International, Inc.. Service: 08/24/2018 by email. [545334] [18-2232] [John Livingstone] [Entered: 08/24/2018 02:23 PM] (2) |
| Aug 24, 2018 | 9 | Entry of appearance for Anthony A. Hartmann as of counsel for Appellants Kaken Pharmaceutical Co., Ltd. and Valeant Pharmaceuticals International, Inc.. Service: 08/24/2018 by email. [545329] [18-2232] [John Livingstone] [Entered: 08/24/2018 02:21 PM] (2) |
| Aug 24, 2018 | 8 | Entry of appearance for Barbara R. Rudolph as of counsel for Appellants Kaken Pharmaceutical Co., Ltd. and Valeant Pharmaceuticals International, Inc.. Service: 08/24/2018 by email. [545324] [18-2232] [John Livingstone] [Entered: 08/24/2018 02:20 PM] (2) |
| Aug 24, 2018 | 7 | Entry of appearance for John D. Livingstone as principal counsel for Appellants Kaken Pharmaceutical Co., Ltd. and Valeant Pharmaceuticals International, Inc.. Service: 08/24/2018 by email. [545321] [18-2232] [John Livingstone] [Entered: 08/24/2018 02:18 PM] (2) |
| Aug 24, 2018 | 6 | Entry of appearance for Joseph T. Jaros as of counsel for Appellees Acrux Limited and Acrux DDS Pty Ltd.. Service: 08/24/2018 by email. [545292] [18-2232] [Tara Raghavan] [Entered: 08/24/2018 01:26 PM] (2) |
| Aug 24, 2018 | 5 | Entry of appearance for Tara M. Raghavan as of counsel for Appellees Acrux Limited and Acrux DDS Pty Ltd.. Service: 08/24/2018 by email. [545288] [18-2232] [Tara Raghavan] [Entered: 08/24/2018 01:23 PM] (2) |
| Aug 24, 2018 | 4 | Docketing Statement for the Appellees Acrux Limited and Acrux DDS Pty Ltd.. Service: 08/24/2018 by email. [545287] [18-2232] [William Rakoczy] [Entered: 08/24/2018 01:21 PM] (4) |
| Aug 24, 2018 | 3 | Certificate of Interest for the Appellees Acrux Limited and Acrux DDS Pty Ltd.. Service: 08/24/2018 by email. [545285] [18-2232] [William Rakoczy] [Entered: 08/24/2018 01:20 PM] (4) |
| Aug 10, 2018 | 1 | Appeal docketed. Received: 08/07/2018. [541999] Entry of Appearance due 08/24/2018. Certificate of Interest is due on 08/24/2018. Docketing Statement due 08/24/2018. Certified List due on 09/19/2018. [CMP] [Entered: 08/10/2018 09:51 AM] (66) |
